RU2286151C2 - Комбинации альфа-2-дельта-лиганда с селективным ингибитором циклооксигеназы-2 - Google Patents
Комбинации альфа-2-дельта-лиганда с селективным ингибитором циклооксигеназы-2 Download PDFInfo
- Publication number
- RU2286151C2 RU2286151C2 RU2004125609/15A RU2004125609A RU2286151C2 RU 2286151 C2 RU2286151 C2 RU 2286151C2 RU 2004125609/15 A RU2004125609/15 A RU 2004125609/15A RU 2004125609 A RU2004125609 A RU 2004125609A RU 2286151 C2 RU2286151 C2 RU 2286151C2
- Authority
- RU
- Russia
- Prior art keywords
- aminomethyl
- acetic acid
- alpha
- acid
- pharmaceutically acceptable
- Prior art date
Links
- 0 *C(*)[C@]1C[C@](CC(O)=O)(CN)CC1 Chemical compound *C(*)[C@]1C[C@](CC(O)=O)(CN)CC1 0.000 description 2
- AKSLDJLYCLFIPI-DTIOYNMSSA-N CCCCCCC1[C@H](CN)CC1 Chemical compound CCCCCCC1[C@H](CN)CC1 AKSLDJLYCLFIPI-DTIOYNMSSA-N 0.000 description 1
- JXSBZOVCVUSLIO-KTOWXAHTSA-N NC[C@@](CC(O)=O)(C1)C2C1CCC2 Chemical compound NC[C@@](CC(O)=O)(C1)C2C1CCC2 JXSBZOVCVUSLIO-KTOWXAHTSA-N 0.000 description 1
- CBDIXAZIJVPJBK-NHCYSSNCSA-N NC[C@@](CC(O)=O)(C1)[C@@H]2[C@H]1CCCCC2 Chemical compound NC[C@@](CC(O)=O)(C1)[C@@H]2[C@H]1CCCCC2 CBDIXAZIJVPJBK-NHCYSSNCSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35929502P | 2002-02-22 | 2002-02-22 | |
| US60/359,295 | 2002-02-22 | ||
| US60/359295 | 2002-02-22 | ||
| US40436502P | 2002-08-19 | 2002-08-19 | |
| US60/404,365 | 2002-08-19 | ||
| US60/404365 | 2002-08-19 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2004125609A RU2004125609A (ru) | 2006-01-27 |
| RU2286151C2 true RU2286151C2 (ru) | 2006-10-27 |
Family
ID=27760521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2004125609/15A RU2286151C2 (ru) | 2002-02-22 | 2003-02-12 | Комбинации альфа-2-дельта-лиганда с селективным ингибитором циклооксигеназы-2 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US20030199567A1 (https=) |
| EP (1) | EP1480639A1 (https=) |
| JP (1) | JP2005523281A (https=) |
| KR (1) | KR20040085216A (https=) |
| CN (1) | CN1635887A (https=) |
| AR (1) | AR038531A1 (https=) |
| AU (1) | AU2003246864A1 (https=) |
| BR (1) | BR0307906A (https=) |
| CA (1) | CA2476438A1 (https=) |
| CO (1) | CO5611109A2 (https=) |
| HN (1) | HN2003000071A (https=) |
| IL (1) | IL162932A0 (https=) |
| MX (1) | MXPA04008175A (https=) |
| NO (1) | NO20043947L (https=) |
| PA (1) | PA8567201A1 (https=) |
| PE (1) | PE20031052A1 (https=) |
| PL (1) | PL372210A1 (https=) |
| RU (1) | RU2286151C2 (https=) |
| TW (1) | TW200303214A (https=) |
| UY (1) | UY27675A1 (https=) |
| WO (1) | WO2003070237A1 (https=) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2571501C2 (ru) * | 2008-09-05 | 2015-12-20 | Грюненталь Гмбх | Фармацевтическая комбинация |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2004054560A1 (en) * | 2002-12-13 | 2004-07-01 | Warner-Lambert Company Llc | Alpha-2-delta ligand to treat lower urinary tract symptoms |
| WO2004084880A1 (en) * | 2003-03-21 | 2004-10-07 | Dynogen Pharmaceuticals, Inc. | METHODS FOR TREATING PAIN USING SMOOTH MUSCLE MODULATORS AND α2δ SUBUNIT CALCIUM CHANNEL MODULATORS |
| WO2004084881A1 (en) * | 2003-03-21 | 2004-10-07 | Dynogen Pharmaceuticals, Inc. | METHODS FOR TREATING FUNCTIONAL BOWEL DISORDERS USING α2δ SUBUNIT CALCIUM CHANNEL MODULATORS WITH SMOOTH MUSCLE MODULATORS |
| DE602004003172T2 (de) * | 2003-03-21 | 2007-09-27 | Dynogen Pharmaceuticals Inc., Waltham | Verfahren zur behandlung von erkrankungen der unteren harnwege mit antimuskarinika und mit modulatoren der alpha-2-delta untereinheit des kalziumkanals |
| US7169812B2 (en) * | 2003-07-01 | 2007-01-30 | Medtronic, Inc. | Process for producing injectable gabapentin compositions |
| NZ545494A (en) * | 2003-09-12 | 2009-10-30 | Pfizer | Combinations comprising alpha-2-delta ligands and serotonin / noradrenaline re-uptake inhibitors |
| GB0322140D0 (en) * | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
| WO2005041976A2 (en) * | 2003-10-23 | 2005-05-12 | Medtronic, Inc. | Injectable gabapentin compositions |
| AR060404A1 (es) * | 2006-04-11 | 2008-06-11 | Novartis Ag | Compuestos organicos utiles como inhibidores de dipeptidil-peptidasa iv |
| US20130012485A1 (en) * | 2006-12-22 | 2013-01-10 | Baeschlin Daniel Kaspar | Organic compounds |
| CA2723358A1 (en) * | 2008-05-05 | 2009-11-12 | Allison B. Reiss | Method for improving cardiovascular risk profile of cox inhibitors |
| KR102631399B1 (ko) | 2018-03-30 | 2024-02-01 | 씨지인바이츠 주식회사 | 폴마콕시브 및 프레가발린을 포함하는 통증 치료용 약제학적 조성물 |
| JP2023548380A (ja) * | 2020-10-28 | 2023-11-16 | トレモー・ファーマシューティカルズ・インコーポレイテッド | 非水溶性ｃｏｘ－２阻害の水性製剤 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| WO1999031057A1 (en) * | 1997-12-16 | 1999-06-24 | Warner-Lambert Company | 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
| RU2168982C2 (ru) * | 1994-07-27 | 2001-06-20 | Варнер-Ламберт Компани | Способ лечения состояния страха или лечения и/или предупреждения состояния паники, очищенный белок, способный связывать габапентин, и фармацевтическая композиция, обладающая успокоительным, противопаническим и противосудорожным действием |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5234929A (en) * | 1992-07-20 | 1993-08-10 | William Chelen | Method of treating motion sickness with anticonvulsants and antitussive agents |
| US5321012A (en) * | 1993-01-28 | 1994-06-14 | Virginia Commonwealth University Medical College | Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance |
| US5420270A (en) * | 1993-10-07 | 1995-05-30 | G. D. Searle & Co. | Aryl substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use |
| US5466823A (en) * | 1993-11-30 | 1995-11-14 | G.D. Searle & Co. | Substituted pyrazolyl benzenesulfonamides |
| US5352638A (en) * | 1994-02-22 | 1994-10-04 | Corning Incorporated | Nickel aluminosilicate glass-ceramics |
| WO1999008670A1 (en) * | 1997-08-20 | 1999-02-25 | Guglietta, Antonio | Gaba analogs to prevent and treat gastrointestinal damage |
| WO1999012537A1 (en) * | 1997-09-08 | 1999-03-18 | Warner-Lambert Company | Analgesic compositions comprising anti-epileptic compounds and methods of using same |
| US6451857B1 (en) * | 1999-03-10 | 2002-09-17 | Warner-Lambert Company | Analgesic compositions comprising anti-epileptic compounds and methods of using same |
| HN2000000224A (es) * | 1999-10-20 | 2001-04-11 | Warner Lambert Co | Aminoacidos biciclicos como agentes farmaceuticos |
| GB9927844D0 (en) * | 1999-11-26 | 2000-01-26 | Glaxo Group Ltd | Chemical compounds |
| JP2003516353A (ja) * | 1999-12-08 | 2003-05-13 | ファルマシア コーポレイション | ヴァルデコキシブ組成物 |
-
2003
- 2003-02-12 RU RU2004125609/15A patent/RU2286151C2/ru not_active IP Right Cessation
- 2003-02-12 EP EP03742460A patent/EP1480639A1/en not_active Withdrawn
- 2003-02-12 MX MXPA04008175A patent/MXPA04008175A/es unknown
- 2003-02-12 JP JP2003569193A patent/JP2005523281A/ja not_active Abandoned
- 2003-02-12 CN CNA038043564A patent/CN1635887A/zh active Pending
- 2003-02-12 WO PCT/IB2003/000534 patent/WO2003070237A1/en not_active Ceased
- 2003-02-12 PL PL03372210A patent/PL372210A1/xx not_active Application Discontinuation
- 2003-02-12 CA CA002476438A patent/CA2476438A1/en not_active Abandoned
- 2003-02-12 BR BR0307906-6A patent/BR0307906A/pt not_active IP Right Cessation
- 2003-02-12 AU AU2003246864A patent/AU2003246864A1/en not_active Abandoned
- 2003-02-12 KR KR10-2004-7013032A patent/KR20040085216A/ko not_active Ceased
- 2003-02-12 IL IL16293203A patent/IL162932A0/xx unknown
- 2003-02-14 US US10/366,798 patent/US20030199567A1/en not_active Abandoned
- 2003-02-17 PE PE2003000166A patent/PE20031052A1/es not_active Application Discontinuation
- 2003-02-19 UY UY27675A patent/UY27675A1/es not_active Application Discontinuation
- 2003-02-20 AR ARP030100547A patent/AR038531A1/es unknown
- 2003-02-21 TW TW092103596A patent/TW200303214A/zh unknown
- 2003-02-21 PA PA20038567201A patent/PA8567201A1/es unknown
- 2003-02-21 HN HN2003000071A patent/HN2003000071A/es unknown
-
2004
- 2004-08-13 CO CO04079024A patent/CO5611109A2/es not_active Application Discontinuation
- 2004-09-21 NO NO20043947A patent/NO20043947L/no unknown
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2168982C2 (ru) * | 1994-07-27 | 2001-06-20 | Варнер-Ламберт Компани | Способ лечения состояния страха или лечения и/или предупреждения состояния паники, очищенный белок, способный связывать габапентин, и фармацевтическая композиция, обладающая успокоительным, противопаническим и противосудорожным действием |
| US5633272A (en) * | 1995-02-13 | 1997-05-27 | Talley; John J. | Substituted isoxazoles for the treatment of inflammation |
| WO1999031057A1 (en) * | 1997-12-16 | 1999-06-24 | Warner-Lambert Company | 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2571501C2 (ru) * | 2008-09-05 | 2015-12-20 | Грюненталь Гмбх | Фармацевтическая комбинация |
| RU2674150C1 (ru) * | 2008-09-05 | 2018-12-05 | Грюненталь Гмбх | Фармацевтическая комбинация |
Also Published As
| Publication number | Publication date |
|---|---|
| PE20031052A1 (es) | 2003-12-24 |
| PL372210A1 (en) | 2005-07-11 |
| AR038531A1 (es) | 2005-01-19 |
| MXPA04008175A (es) | 2004-11-26 |
| BR0307906A (pt) | 2004-12-21 |
| EP1480639A1 (en) | 2004-12-01 |
| IL162932A0 (en) | 2005-11-20 |
| CO5611109A2 (es) | 2006-02-28 |
| HN2003000071A (es) | 2003-11-24 |
| AU2003246864A1 (en) | 2003-09-09 |
| CA2476438A1 (en) | 2003-08-28 |
| CN1635887A (zh) | 2005-07-06 |
| PA8567201A1 (es) | 2003-11-12 |
| KR20040085216A (ko) | 2004-10-07 |
| WO2003070237A1 (en) | 2003-08-28 |
| US20030199567A1 (en) | 2003-10-23 |
| NO20043947L (no) | 2004-09-21 |
| RU2004125609A (ru) | 2006-01-27 |
| UY27675A1 (es) | 2003-09-30 |
| JP2005523281A (ja) | 2005-08-04 |
| TW200303214A (en) | 2003-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2286151C2 (ru) | Комбинации альфа-2-дельта-лиганда с селективным ингибитором циклооксигеназы-2 | |
| US20050004177A1 (en) | Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor | |
| US20070203212A1 (en) | Method of treating osteoarthritis | |
| JP2009521408A (ja) | Ｃｄｃ２様キナーゼ（ＣＬＫ）のモジュレータおよびその使用方法 | |
| PT1536782E (pt) | Combinação sinérgica de um ligando alfa-2-delta e um inibidor pdev para ser utilizada no tratamento da dor | |
| AU2008233202A1 (en) | Alpha-2-delta ligand to treat lower urinary tract symptoms | |
| JP2005539020A (ja) | マトリクスメタロプロテイナーゼ阻害物質としてのクロモン誘導体 | |
| US20050026979A1 (en) | Methods for treating inflammation and inflammation-associated diseases with a statin and ether | |
| AU2003255937A1 (en) | Method of treating osteoarthritis | |
| US20040034085A1 (en) | Combination of an allosteric inhibitor of matrix metalloproteinase-13 with a selective inhibitor of cyclooxygenase-2 that is not celecoxib or valdecoxib | |
| MXPA05000729A (es) | Combinacion de un inhibidor alosterico de metaloproteinasa-13 de matriz con celecoxib o valdecoxib. | |
| US20050004196A1 (en) | Pharmaceutical compositions including an ether and selective COX-2 inhibitor and methods for using such | |
| MXPA04005557A (es) | Metodo para tratar la osteoartritis. | |
| JP2006502991A (ja) | マトリックスメタロプロテイナーゼ−１３のアロステリックアルキン阻害剤とセレコキシブまたはバルデコキシブではないシクロオキシゲナーゼ−２の選択的阻害剤との組合せ物 | |
| MXPA05000476A (es) | Combinacion de un inhibidor alquino alosterico de metaloproteinasa-13 de matriz con celecoxib o valdecoxib. | |
| US20080293746A1 (en) | Combinations comprising pregabalin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20070213 |